US 12286400
Isofagomine salts, methods of use and formulations
granted A61KA61K31/445A61K38/47
Quick answer
US patent 12286400 (Isofagomine salts, methods of use and formulations) held by Takeda Pharmaceutical Company Limited expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/445, A61K38/47, A61K45/06, A61P